Antagonism of 5-HT3 receptor mediated currents in murine N1E-115 neuroblastoma cells by (+)-tubocurarine

https://doi.org/10.1016/0304-3940(90)90796-CGet rights and content

Abstract

5-HT3 receptor-mediated membrane currents were recorded from voltage-clamped clonal N1E-115 neuroblastoma cells. The inward current response to ionophoretically applied serotonin (5-HT) was reversibly antagonised by the 5-HT3 receptor antagonists GR 38032F and metoclopramide with IC50 values of 0.2 nM and 14 nM, respectively. Low concentrations of (+)-tubocurarine ((+)-Tc) also blocked the response to 5-HT (IC50 = 0.8 nM), but other nicotinic cholinoceptor antagonists (gallamine, vecuronium and trimetaphan) were ineffective when applied at a relatively high concentration (1 μM). Blockade by (+)-Tc was neither voltage- nor use-dependent, suggesting that (+)-Tc does not block 5-HT-activated ion channels in N1E-115 cells.

References (19)

There are more references available in the full text version of this article.

Cited by (40)

  • Nicotinic potentiation of frog retinotectal transmission in tectum layer F by α3β2, α4β2, α2β4, α6β2, or α7 acetylcholine receptor subtypes

    2015, Medicina (Lithuania)
    Citation Excerpt :

    An application of pilocarpine and oxotremorine-M, the specific muscarinic acetylcholine receptor agonists, had no effect on the retinotectal synaptic transmission. These results show that d-tubocurarine acts on the nicotinic acetylcholine receptors, not on the 5-HT3 and/or GABAA receptors [20,21]. The localization of these nicotinic acetylcholine receptors was of the presynaptic origin since the effect of d-tubocurarine was accompanied by a change (increase) in the paired-pulse facilitation.

  • Mapping spatial relationships between residues in the ligand-binding domain of the 5-Ht<inf>3</inf> receptor using a molecular ruler

    2010, Biophysical Journal
    Citation Excerpt :

    To take full advantage of the double-mutant cycle analysis, we employed a panel of ligands with a number of defined small changes in structure. One ligand that can be altered in a number of ways is dTC, a competitive antagonist of both AChRs (19) and 5-HT3Rs (20). dTC has a 1- to 2000-fold higher affinity for the murine 5-HT3R than the human receptor, and it was shown that the regions responsible for this species difference are located in the amino terminal extracellular domain (21).

View all citing articles on Scopus
View full text